1. Home
  2. WVE vs AVEX Comparison

WVE vs AVEX Comparison

Compare WVE & AVEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$5.06

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo AEVEX Corp. Class A Common Stock

AVEX

AEVEX Corp. Class A Common Stock

N/A

Current Price

$17.72

Market Cap

1.2B

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
AVEX
Founded
2012
N/A
Country
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Aerospace
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2015
2026

Fundamental Metrics

Financial Performance
Metric
WVE
AVEX
Price
$5.06
$17.72
Analyst Decision
Strong Buy
Analyst Count
16
0
Target Price
$29.81
N/A
AVG Volume (30 Days)
3.2M
1.4M
Earning Date
04-28-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$3,704,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$85.67
N/A
P/E Ratio
N/A
$1,876.00
Revenue Growth
149.43
N/A
52 Week Low
$5.01
$13.07
52 Week High
$21.73
$23.62

Technical Indicators

Market Signals
Indicator
WVE
AVEX
Relative Strength Index (RSI) 39.27 47.73
Support Level $5.02 $17.30
Resistance Level $6.39 $18.81
Average True Range (ATR) 0.31 1.48
MACD -0.01 -0.34
Stochastic Oscillator 2.26 13.13

Price Performance

Historical Comparison
WVE
AVEX

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About AVEX AEVEX Corp. Class A Common Stock

AEVEX Corp is a defense technology company delivering next-generation navigation and autonomy, uncrewed systems, and adaptable mission solutions engineered to need, delivered at speed, and built for the modern battlespace. Its solutions are sold to agencies and organizations within the DoW, SOF, IC, and allied international partners. The group offers products and solutions such as CompassCore, CompassVision, CompassEngage, Precision Strike Systems, Unmanned Surface Vessels, Long Endurance Aircraft, Additive Manufacturing, Full Spectrum Airborne ISR, Aircraft Modification and Testing, and Others.

Share on Social Networks: